2003 Formulas for Verification of Foreign Patented Drug Prices

France

  • FP given in SEMPEX in euros
  • FP (reported in the formulary under column "Px–Achat") is directly comparable to the PP reported by the patentee
  • The WP is derived as follows:
If: FP ≤ 22.90 WP = FP/1.1074
FP > 22.90 20.68 + (PAHT − 22.90)/1.06
  • No price comparable to the HP reported by patentee

Germany

  • FP given in Rote Liste in euros
  • FP includes 16% VAT; FPN = FP/1.16
  • The PP is derived as follows:
If : 0 < FPN ≤ 2.04 PP= FPN/1.68
2.04 < FPN ≤ 2.16 PP = FPN − 0.8296
2.16 < FPN ≤ 6.28 PP = FPN/1.62
6.28 < FPN ≤ 6.62 PP = FPN − 2.4056
6.62 < FPN ≤ 11.49 PP = FPN/1.57
11.49 < FPN ≤ 12.89 PP = FPN − 4.161
12.89 < FPN ≤ 17.99 PP = FPN/1.48
17.99 < FPN ≤ 19.39 PP = FPN − 5.8272
19.39 < FPN ≤ 27.79 PP = FPN/1.43
27.79 < FPN ≤ 30.99 PP = FPN − 8.3506
30.99 < FPN ≤ 42.49 PP = FPN/1.37
42.49 < FPN ≤ 49.29 PP = FPN − 13.2978
49.29 < FPN ≤ 707.08 PP = FPN/1.30
FPN > 707.08 PP = (FPN − 118.24)/1.08263
  • The WP is derived as follows:
If : 0 < PP ≤ 1.01 WP = PP/1.21
1.01 < PP ≤ 1.05 WP = PP − 0.1764
1.05 < PP ≤ 2.04 WP = PP/1.20
2.04 < PP ≤ 2.08 WP = PP − 0.34
2.08 < PP ≤ 3.05 WP = PP/1.195
3.05 < PP ≤ 3.12 WP = PP − 0.4992
3.12 < PP ≤ 4.34 WP = PP/1.19
4.34 < PP ≤ 4.44 WP = PP − 0.69
4.44 < PP ≤ 7.14 WP = PP/1.185
7.14 < PP ≤ 7.31 WP = PP − 1.11555
7.31 < PP ≤ 10.79 WP = PP/1.18
10.79 < PP ≤ 12.69 WP = PP − 1.638
12.69 < PP ≤ 51.19 WP = PP/1.15
51.19 < PP ≤ 62.29 WP = PP − 6.67
62.29 < PP ≤ 766.93 WP = PP/1.12
PP > 766.93 WP = (PP − 61.63)/1.03
  • No price comparable to the HP reported by patentee

Italy

  • FP given in l'Informatore Farmaceutico in Italian liras
  • FP includes a 10% VAT; FPN = FP/1.10
  • PP = FPN x 0.733
  • WP = FPN x 0.6665
  • No price comparable to the HP reported by patentee

Sweden

  • FP given in Prislista in Swedish kronas
  • The PP is derived as follows:
If: FP ≤ 64.39 PP = (FP − 19.80)/1.30
64.39 < FP ≤ 113.30 PP = (FP − 23.30)/1.20
113.30 < FP ≤ 356.30 PP = (FP − 32.30)/1.08
356.30 < FP ≤ 2,175.30 PP = (FP − 35.30)/1.07
2,175.30 < FP ≤ 5,199.9 PP = (FP − 145.30)/1.015
FP > 5,199.9 PP = FP − 220
  • The WP is derived as follows:
If: FP ≤ 64.39 WP = (FP − 19.80)/(1.30 x 1.032)
64.39 < FP ≤ 113.30 WP = (FP − 23.30)/(1.20 x 1.032)
113.30 < FP ≤ 356.30 WP = (FP − 32.30)/(1.08 x 1.032)
356.30 < FP ≤ 2,175.30 WP = (FP − 35.30)/(1.07 x 1.032)
2,175.30 < FP ≤ 5,199.9 WP = (FP − 145.30)/(1.015 x 1.032)
FP > 5,199.9 WP = (FP − 220)/1.032
  • No price comparable to the HP reported by patentee

Switzerland

  • FP given in Switzerland formulary (Medwin website) in Swiss francs
  • FP is directly comparable to the WP reported by the patentee
  • No prices comparable to the HP and the PP reported by patentee

United Kingdom

  • FP given in the Monthly Index of Medical Specialties (MIMS) in UK pounds
  • FP is directly comparable to PP reported by the patentee
  • WP = FP x 0.875
  • No price comparable to the HP reported by patentee

United States

  • No regulated mark–ups
  • Prices given in US dollars
  • The Direct Price is directly comparable to the PP and/or the HP reported by the patentee
  • The Wholesale Acquisition Cost (WAC) price is directly comparable to the WP reported by the patentee
  • The Federal Supply Schedule (FSS) price has been required by the PMPRB since 1998 and included in IPC tests since 2000
Date modified: